US-based PCI Pharma Services has expanded the bottling line capacity at its commercial packaging facility in Rockford, Illinois.

This expansion is expected to increase the plant’s capacity to produce 100 million bottles additionally per year and help the company meet growing customer demand.

It also follows a series of investments made by the company in capacity expansion initiatives globally, including multiple facility enlargements, cold chain and ultra-cold storage extension. It includes installations of additional packaging lines and expansion of its serialisation solutions.

The company commenced the construction of additional packaging suites at the Rockford plant in March and added high-speed tablet filling, cartoning, as well as in-line serialisation and aggregation capabilities.

PCI Pharma Services Rockford vice-president and general manager Angella Sutthiwan said: “I am pleased to share this news regarding our continued investment to support the needs of our customers.

“This multi-million dollar investment demonstrates our commitment to providing both operational flexibility and expansive capacity.”

“Choosing the right contract packaging business partner, one that can consistently and reliably deliver high-quality product quickly, while providing the flexibility to manage the peaks and valleys of changing forecasts, is critical to our customers.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“This multi-million dollar investment demonstrates our commitment to providing both operational flexibility and expansive capacity in meeting those demands in order to bring life-saving medicines to patients around the world.”

Last month, the company announced a more than $20m investment in expanded Biotech clinical and commercial packaging and release testing capabilities at its centre of excellence in Philadelphia, US.